IGF2BP2诱导的circRNF20通过HuR/CDCA4轴促进乳腺癌细胞的增殖
Shu-Tao Wu1, Xiao-Li Hou2, Fei Wang1,3
1Yangzhou University Medical College, Yangzhou, China.
The Kaohsiung journal of medical sciences
|February 19, 2025
概括
胰岛素样生长因子2mRNA结合蛋白2 (IGF2BP2) 通过稳定circRNA RNF20促进乳腺癌细胞的增殖,增强HuR/CDCA4通路. 这一发现为乳腺癌治疗提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 乳腺癌 (BC) 仍然是全球癌症相关死亡的主要原因.
- 了解驱动BC扩散的分子机制对于开发有效疗法至关重要.
- 胰岛素样生长因子2 mRNA结合蛋白2 (IGF2BP2) 已与各种癌症有关,但其在BC增殖中的特定作用需要进一步阐明.
研究的目的:
- 研究IGF2BP2影响乳腺癌细胞增殖的机制.
- 确定参与IGF2BP2介导的BC进展的关键分子参与者和途径.
主要方法:
- 定量实时PCR (RT-qPCR) 和西式斑点检测用于评估基因和蛋白质表达.
- 细胞增殖试验 (CCK-8,殖民地形成,EDU染色) 来评估细胞生长.
- RNA免疫沉 (RIP) 和RNA拉下测试以确定分子相互作用.
- 裸体老鼠异种移植模型,以验证体内疗效.
主要成果:
- 与正常细胞相比,IGF2BP2,circRNA RNF20 (circRNF20) 和CDCA4在BC细胞中显著上调.
- 抑制IGF2BP2抑制了BC细胞的增殖.
- IGF2BP2与circRNF20结合,防止其降解并促进circRNF20-HuR相互作用,导致CDCA4表达的增加.
- 过度表达circRNF20或CDCA4可以抵消IGF2BP2沉默的抑制作用.
结论:
- IGF2BP2通过稳定circRNF20促进乳腺癌细胞增殖,这有助于HuR/CDCA4轴.
- 这项研究阐明了BC进展背后的新型分子机制.
- 准IGF2BP2/circRNF20/HuR/CDCA4通路为乳腺癌提供了一个潜在的治疗策略.
更多相关视频
06:36A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
10.7K
06:35A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
4.4K
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
